CXCL12 and cancer: Cultivation of cancer cells with CXCL12 leads to increased resistance/Activation of the FAK, Akt, and ERK pathways leads to a subsequent decrease in the BAX/BCL-2 ratio and the inhibition of downstream caspase 3